Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | DHFR | P00374 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL152875 | 0.85 | S100B (0.31) | — | |
| SCHEMBL128645 | 0.82 | S100B (0.47) | RAB9A | |
| SCHEMBL128462 | 0.80 | NSD2 (0.36) | RAB9A | |
| SCHEMBL127321 | 0.76 | ADRA2A (0.35) | RAB9A | |
| SCHEMBL179662 | 0.70 | MEN1 (0.37) | PTPN1DHFR | |
| SCHEMBL8524528 | 0.69 | ALDH1A1 (0.42) | PTPN1DHFR | |
| Sulfuric Acid SCHEMBL14324849 | 0.67 | ALDH1A1 (0.42) | — | |
| SCHEMBL6580919 | 0.67 | S100B (0.62) | PTPN1DHFR | |
| SCHEMBL150568 | 0.66 | S100B (0.51) | RAB9A | |
| SCHEMBL11037811 | 0.64 | CHKA (0.34) | PTPN1DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8691979-B2 | Methods of chemical synthesis of diaminophenothiazinium compounds involving the use of persulfate oxidants | WISTA LABORATORIES LTD. (SG) | 2014-04-08 | — | — | US | disclosed |
| US-20120058995-A1 | METHODS OF CHEMICAL SYNTHESIS OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INVOLVING THE USE OF PERSULFATE OXIDANTS | WISTA LABORATORIES LTD. (SG) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120058995-A1 | METHODS OF CHEMICAL SYNTHESIS OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INVOLVING THE USE OF PERSULFATE OXIDANTS | TST, TPMT, MGMT | PTPN1 4020/4885DHFR 140/4885RAB9A 3655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.